IGF-1 levels are influenced by age, metabolic syndrome, nutritional intake, IGFBP-mediated bioavailability, and hormonal status (36–38, 50), while laboratory assays and sampling times varied widely among included studies. The gene discussed is IGF1; the disease is metabolic syndrome.